CVS Health (CVS) Tops Q1 EPS by 33c, Raises FY EPS Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- S&P 500, Nasdaq close lower, dragged by Alphabet and megacap tech; focus on Iran
- Oil settles down more 3% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Needham Starts NeoVolta (NEOV) at Buy
- Spain's ex-transport minister sentenced to 24 years for corruption
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
CVS Health Reports Strong First Quarter Results
May 4, 2021 6:30 AM EDTWOONSOCKET, R.I., May 4, 2021 /PRNewswire/ -- CVS Health Corporation (NYSE: CVS) today announced operating results for the three months ended March 31, 2021.
First Quarter Highlights:
Total revenues increased to $69.1 billion, up 3.5% compared to prior year GAAP diluted EPS of $1.68, up 9.8% compared to prior year Adjusted EPS of $2.04, up 6.8% compared to prior year Generated cash flow from operations of $2.9 billion2021 Full Year Guidance:
Raised GAAP diluted EPS guidance range to $6.24 to $6.36 from $6.06 to $6.22... More